Form D · Pharmaceuticals
Revolution Medicines, Inc.
Redwood City, CA · CIK 0001628171
Offering snapshot reported Nov 15, 2019 · SEC filing
- Reported sold
- $100M Offering amount: $100M
- Investors reported
- 34 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jun 5, 2019 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Nov 15, 2019 | Initial | $100,287,058 | No comparison | 34 | SEC filing |
| Jul 10, 2018 | Initial | $56,430,920 | No comparison | 18 | SEC filing |
| Dec 21, 2016 | Initial | $47,524,999 | No comparison | 4 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-353544
Source: Form D, filed Nov 15, 2019. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Elizabeth Anderson | Director |
| Michael Bonney | Director |
| Alexis Borisy | Director |
| Neil Exter | Director |
| Mark A. Goldsmith | Director, Executive |
| Margaret Horn | Executive |
| Steve Kelsey | Executive |
| Laurence Lasky | Director |
| Ryan Martins | Executive |
| Vincent Miller | Director |
| Thilo Schroeder | Director |
| Barbara Weber | Director |
| Luan Wilfong | Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
700 Saginaw Dr
Redwood City, CA, 94063
Redwood City, CA, 94063